Bret Jensen was chief investment strategist from 2008-2011 for Simplified Asset Management (S.A.M.), a small long/short hedge fund based in Miami. The fund was in top 5% of long/short hedge funds for total return in its first full year (2009) as ranked by Hedgeco fund database (more than 450 funds in category). Jensen has nearly 20 years of experience in the financial services industry, including more than a decade of managerial experience at American Express. He holds a Bachelor of Science degree in finance from Arizona State University. His personal blog is at http://www.bretjenseninvests.com. Jensen acts as corporate secretary for Florida Alternative Investment Association, which encompasses more than 100 managers managing more than $30 billion in assets under management. Follow Bret on Twitter: @Bret_Jensen.
Financials and energy ETFs aren't faring well in the current environment, but there still is a way to make money on them.
It's hard to put much stock in achieving real progress on trade talks with China, and with the yield curve inverting and global economies sagging it's time to be on guard in the markets.
Stemline Therapeutics and Flexion Therapeutics both saw their shares climb on positive news developments.
They're the most important executive at most small developmental or early commercialization concerns.
It will take time to determine the impact of new tariffs on consumer prices, business bottom lines and the achievement of a trade deal with China.
AbbVie and Bristol-Myers Squibb are two pharmaceutical giants where insiders have snatched up big blocks of stock.
Striking out is painful, but is not as impactful as missing out on the next potential home run because you're still brooding about whiffing on your last investment.
The trio to keep an eye on are U.S.-China trade talks, business investment and political rhetoric.
Jounce Therapeutics and Ocular Therapeutix each provided investors with positive news morsels last week.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.